文献速递主动脉疾病

低轮廓Altura腔内移植物系统用于腹主动脉瘤腔内修复:择期与急诊情况下的初步结果

Low-Profile Altura Endograft System for Endovascular Abdominal Aorta Aneurysm Repair. Preliminary Results in Elective and Emergent Situations.
PubMed 文献 · Ann Vasc Surg · 2023-01-11

单中心回顾性研究评估Altura腔内移植物治疗肾下腹主动脉瘤的12个月结局,纳入2021年1月至2022年8月共34例(择期25例、急诊8例)患者。择期与急诊技术成功率均为100%,院内死亡0例,中位随访12个月(IQR 12-18)临床成功率和免于再干预率均为97%。作者认为初步结果似乎有前景,但需更大样本的进一步研究。

要点

  • 择期与急诊情况下Altura腔内移植物技术成功率均为100%。
  • 中位随访12个月(IQR 12-18),临床成功率和免于再干预率均为97%。
  • 1例(3%)急诊术后7天因大面积肺栓塞死亡,1例(3%)髂支血栓形成。

核心结论

  • Altura腔内移植物的初步结果似乎有前景,提示该移植物在择期或急诊情况下均可安全使用。
  • 作者认为需要更大样本的进一步研究来记录其技术和临床性能,尤其是在急诊情况下,这方面可能有改进空间。

研究设计与样本

  • 单中心回顾性研究,纳入2021年1月至2022年8月所有使用Altura腔内移植物行EVAR的患者。
  • 共回顾34例(择期25例、急诊8例)肾下腹主动脉瘤患者。
  • 评估结局包括死亡率、技术和临床成功(免于手术相关死亡、内漏、移位、血栓形成和再干预)以及免于再干预率。

主要发现

  • 择期与急诊情况下Altura腔内移植物技术成功率均为100%。
  • 院内死亡0例;1例(3%)急诊AAA修复患者出院后7天因大面积肺栓塞意外死亡。
  • 中位随访12个月(IQR 12-18),临床成功率和免于再干预率均为97%。
  • 1例患者术后第3个月出现致残性间歇性跛行,CTA显示一侧髂支腔内移植物血栓形成(3%),行股股旁路术后恢复顺利、症状立即缓解。
  • 1例II型内漏在第6个月自行消退;12例(35%)记录到瘤囊缩小(>3 mm),其余22例(65%)瘤囊大小稳定。

局限性

  • 原文标题及结论写明为初步结果(preliminary results)。
  • 作者指出需要更大样本的进一步研究来记录其技术和临床性能。
  • 作者指出急诊情况下的表现可能有改进空间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this study was to assess the Altura endoprosthesis outcomes up to 12 months for patients affected by infrarenal abdominal aortic aneurysms (AAA) either in elective or emergent situations. METHODS: This was a single-center retrospective study identifying all patients undergoing endovascular aneurysm repair (EVAR) with the Altura endoprosthesis from January 2021 to August 2022. Outcomes evaluated included mortality, technical and clinical success (freedom from procedure-related death, endoleak, migration, thrombosis, and reintervention), and the freedom from reintervention rate. RESULTS: A total of 34 (25 elective and 8 emergent) patients who underwent AAA with Altura endoprosthesis were retrospectively reviewed. The technical success of the Altura endograft either in elective or emergent situations was 100%. There was no inhospital mortality, but 1 (3%) patient who underwent AAA repair emergently, died unexpectedly 7 days after the discharge due to massive pulmonary embolism. The clinical success and the freedom from reintervention during the median follow-up of 12 months (interquartile range [IQR] 12-18), were 97%. One patient presented with disabling intermittent claudication at third month postoperatively, and the computed tomographic angiography (CTA) revealed thrombosis of one of the iliac endografts (3%). The patient underwent femorofemoral bypass with an uneventful postoperative course and immediate relief of the symptoms. One type II endoleak was spontaneously resolved on the sixth month. Sac shrinkage (>3 mm) was registered in 12 patients (35%), but the sac size was stable in the remaining 22 (65%) patients. CONCLUSIONS: The preliminary outcomes of the Altura endograft seem to be promising, suggesting that the endograft could be safely used either in elective or emergent situations. Further studies with a major number of participants are needed to document its technical and clinical performance, especially in emergency situations that could be amenable to improvement.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Karaolanis GI, Hadjis D, Samara E, et al. Low-Profile Altura Endograft System for Endovascular Abdominal Aorta Aneurysm Repair. Preliminary Results in Elective and Emergent Situations. Ann Vasc Surg. 2023. PMID: 36639096. doi:10.1016/j.avsg.2023.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。